Company Filing History:
Years Active: 2007
Title: Enca Martin-Rendon: Innovator in Retroviral Vector Systems
Introduction
Enca Martin-Rendon is a notable inventor based in Sandford-on-Thames, GB. He has made significant contributions to the field of biotechnology, particularly in the development of retroviral vector systems. His work is essential for advancing treatments for neurodegenerative disorders.
Latest Patents
Enca holds 1 patent for a retroviral vector system. This patent includes retroviral vector genomes and vector systems that comprise these genomes. Specifically, it features a retroviral vector genome that includes two or more NOIs, operably linked by one or more Internal Ribosome Entry Site(s). Additionally, it encompasses a lentiviral vector genome suitable for treating neurodegenerative disorders, which encodes tyrosine hydroxylase, GTP-cyclohydrolase I, and optionally, Aromatic Amino Acid Dopa Decarboxylase.
Career Highlights
Enca is currently associated with Oxford Biomedia (UK) Limited, where he continues to innovate in the field of gene therapy. His work has the potential to impact the treatment of various neurological conditions, showcasing his commitment to improving patient outcomes.
Collaborations
Enca has collaborated with esteemed colleagues such as Alan John Kingsman and Nicholas D Mazarakis. These partnerships have further enhanced the research and development of vector systems in biotechnology.
Conclusion
Enca Martin-Rendon is a pioneering inventor whose work in retroviral vector systems is paving the way for new treatments in neurodegenerative disorders. His contributions to the field are invaluable and continue to inspire advancements in biotechnology.